Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International Inc (BKYI) delivers innovative biometric authentication solutions for enterprise security and identity management. This dedicated news hub provides investors and industry professionals with complete access to official company announcements and verified developments.
Track all critical updates including earnings disclosures, product launches, strategic partnerships, and regulatory filings. Our curated collection ensures efficient monitoring of BKYI's advancements in fingerprint biometrics, identity-as-a-service platforms, and cybersecurity innovations.
Discover updates on key operational areas: deployment of PortalGuard® identity solutions, government sector contracts, and advancements in passwordless authentication technology. Content is rigorously verified to support informed decision-making in the biometrics and cybersecurity markets.
Bookmark this page for streamlined access to BIO-key's latest milestones. Check regularly for authoritative updates on one of the biometric industry's most dynamic providers of hardware and software authentication solutions.
BIO-key International (NASDAQ: BKYI) announced its PortalGuard IAM solution is now utilized by a division of the US Department of Justice, enhancing secure authentication for systems access. This multi-factor solution aims to improve security while reducing user friction and help desk costs. The announcement highlights BIO-key's commitment to supporting national security programs and its experience with law enforcement agencies facing evolving threats.
BIO-key International, Inc. (NASDAQ: BKYI) announced the expansion of its PortalGuard identity and access management solution for GATX Corporation, specifically for its Rail Europe operations. With a shift to remote work due to COVID-19, GATX faced increasing Help Desk costs and security challenges. PortalGuard aims to enhance password management, improve user experience, and reduce IT costs. Mark Cochran, President of BIO-key, emphasized the solution's balance of security and usability, highlighting the ongoing need for effective cybersecurity measures in remote environments.
BIO-key International (BKYI) will participate in the LD Micro Virtual Main Event 2020 Investor Conference on December 15, 2020. Chairman and CEO Mike DePasquale is scheduled to present at 3:20 PM ET, followed by a Q&A session. The event, taking place on December 14-15, features over 200 small and micro-cap companies and aims to provide a more engaging experience for attendees. For more details or to register, visit the LD Micro website.
BIO-key International (NASDAQ: BKYI) announced the launch of PortalGuard IDaaS, a secure, scalable identity-as-a-service platform. This cloud-based service utilizes biometrics and offers a flexible approach to identity and access management (IAM). The solution has already processed millions of authentication transactions, aiming to enhance security in work-from-anywhere scenarios. Gartner predicts a significant growth in IAM SaaS usage, driven by the pandemic. CEO Michael DePasquale emphasized that this launch reflects BIO-key's commitment to innovation and flexibility in IAM solutions.
BIO-key International (Nasdaq: BKYI) announced that its Chairman & CEO Michael DePasquale will present at the 17th Annual Imperial Capital Security Investor Conference on December 2, 2020, at 12:30 pm ET. The event is a key platform connecting about 70 security-focused companies with 500 investors and leaders. Held virtually over two days, the conference aims to showcase companies providing advanced security solutions across Consumer, Enterprise, and Government markets, underlining BIO-key's commitment to innovation in identity and access management.
BIO-key International (NASDAQ: BKYI) has partnered with Prominic.NET to deploy its PortalGuard IAM solution for a U.S. Department of Defense agency. This collaboration aims to enhance user access security to the agency's enterprise applications using secure smart card authentication. The PortalGuard solution features Single Sign-On capabilities and supports Personal Identity Verification (PIV) credential smart card authentication, while providing traditional two-factor authentication for users without PIV. This partnership signifies an important milestone in BIO-key's mission-critical security market.
BIO-key International, Inc. (Nasdaq: BKYI) announced a 1-for-8 reverse stock split effective on November 20, 2020, following shareholder approval on November 16. This decision aims to comply with Nasdaq's minimum closing bid maintenance requirement. Following the split, the number of outstanding shares will decrease from approximately 62.4 million to about 7.8 million. The company reported $18.4 million in cash as of September 30, 2020, translating to approximately $2.36 per share on a split-adjusted basis. CEO Michael DePasquale emphasized that this move is crucial for financial stability and future growth.
BIO-key International, Inc. (Nasdaq: BKYI) reported a significant Q3 2020 performance, with revenues surpassing $943K, over double that of Q3 2019's $453K, largely due to the PistolStar/PortalGuard acquisition. The company's gross margin improved to 78%, a substantial recovery from a negative margin in the prior year. Despite an operating loss of $1.1M and a net loss of $3.3M, BIO-key ended the quarter with $18.4M in cash, bolstered by a recent public offering. The firm anticipates continued growth and expansion in global markets, particularly in Africa, with key projects expected to commence soon.
BIO-key International, Inc. (NASDAQ: BKYI) will host a conference call on November 12, 2020, at 10 a.m. ET to discuss its third quarter 2020 financial results. The company will release the results before the market opens. Key executives, including Chairman & CEO Mike DePasquale and CFO Cecilia Welch, will participate. Investors can access the call via dial-in numbers or through a live webcast, available for replay for three months. BIO-key specializes in identity access management and biometric solutions.
BIO-key International (NASDAQ: BKYI) announced that Marion Technical College has selected its identity and access management solutions to implement Two-Factor Authentication (2FA) and Single Sign-On (SSO) for critical applications. This move aims to enhance security and improve user experience for students and faculty accessing platforms like Office 365 and Canvas. The integration of SSO with 2FA is expected to reduce login frustrations and enhance data protection. BIO-key's President highlighted the increasing demand for cybersecurity in educational institutions.